VanEck Associates’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$112K Buy
30,609
+2,072
+7% +$7.85K ﹤0.01% 1301
2025
Q4
$84K Sell
28,537
-19,823
-41% -$54.3K ﹤0.01% 1333
2025
Q3
$117K Buy
+48,360
New +$155K ﹤0.01% 1318

Other funds holding BAK

VanEck Associates's BAK Position: Q1 2026 in Review

VanEck Associates increased its Braskem (BAK) stake by 7.3% in Q1 2026, buying an estimated $7.85K and bringing the position to 30,609 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1301.

VanEck Associates first reported a position in BAK in Q3 2025 and has held it in 3 quarters since. The position peaked at $117K in Q3 2025. 64 funds tracked by Wall St. Rank hold BAK as of Q1 2026.

  • VanEck Associates held 30,609 shares of Braskem worth $112K as of Q1 2026.
  • VanEck Associates bought 2,072 Braskem shares in Q1 2026, an estimated $7.85K.
  • Braskem made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #1301 holding.
  • VanEck Associates first reported a position in Braskem in Q3 2025 and has held it in 3 quarters since.
  • VanEck Associates's Braskem position peaked at $117K in Q3 2025.
  • 64 funds tracked by Wall St. Rank held Braskem as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.